Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company, reports the Associated Press.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback